Recent Updates
Recently added Catalysts
DMAC Positive Sentiment Score: 70/100

DiaMedica Therapeutics to Present at the 16th Annual Craig-Hallum Institutional Investor Conference on May 29, 2019

Wednesday, May 22, 2019 1 min read
Key Takeaway: DiaMedica Therapeutics Inc. will present at the 16th Annual Craig-Hallum Institutional Investor Conference on May 29, 2019. The event will take place at the Depot Renaissance Minneapolis Hotel, where management will hold one-on-one meetings with investors. DiaMedica specializes in developing treatments for chronic kidney diseases and neurological disorders.

Market Sentiment Analysis

POSITIVE FACTORS

  • DiaMedica is actively engaging with investors at a notable conference.
  • The company is focused on developing treatments for significant health issues.
  • Participation in the conference may enhance investor interest and visibility.

Full Press Release Details

MINNEAPOLIS, May 22, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that it will be participating in the 16th Annual Craig-Hallum Institutional Investor Conference on Wednesday, May 29, 2019, at the Depot Renaissance Minneapolis Hotel in Minneapolis, MN.  Management will be available to participate in one-on-one meetings with investors and attendees can contact their Craig-Hallum representative to arrange a meeting.

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney diseases and neurological disorders. The Company currently has an ongoing phase II study in acute ischemic stroke and a phase Ib study in chronic kidney disease. DiaMedica’s shares are listed on The Nasdaq Capital Market under the trading symbol “DMAC.”

For more information, please visitwww.diamedica.com.Contact:

Scott KellenChief Financial OfficerPhone: (763) 496-5118skellen@diamedica.com
Paul PapiVice President of Business DevelopmentPhone: (617) 899-5941info@diamedica.com

Frequently Asked Questions

When is DiaMedica presenting at the conference?

DiaMedica will present at the conference on May 29, 2019.

Where is the Craig-Hallum conference held?

The conference will take place at the Depot Renaissance Minneapolis Hotel.

What is DiaMedica's focus area?

DiaMedica focuses on developing treatments for chronic kidney diseases and neurological disorders.

How can investors meet DiaMedica's management?

Investors can arrange one-on-one meetings with DiaMedica's management through their Craig-Hallum representative.

Tags: DMAC Viatris Investor Conferences Healthcare DiaMedica Therapeutics investor conference chronic kidney disease neurological disorders
Last updated: May 22, 2019